RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Elsevier 2024-02-01
Σειρά:	Neoplasia: An International Journal for Oncology Research
Θέματα:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

Παρόμοια τεκμήρια

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
ανά: Wentao Si, κ.ά.
Έκδοση: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
ανά: Natalia B. Fernández, κ.ά.
Έκδοση: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
ανά: Bradley A. Hancock, κ.ά.
Έκδοση: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
ανά: Liang Gao, κ.ά.
Έκδοση: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
ανά: Guoyu Wu, κ.ά.
Έκδοση: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
ανά: Alexander H. Chung, κ.ά.
Έκδοση: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
ανά: Jianbo Zheng, κ.ά.
Έκδοση: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
ανά: Meng Wang, κ.ά.
Έκδοση: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
ανά: Anuradha Illendula, κ.ά.
Έκδοση: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
ανά: Margarite D. Matossian, κ.ά.
Έκδοση: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
ανά: Adam Hermawan, κ.ά.
Έκδοση: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
ανά: Adiba S. Khan, κ.ά.
Έκδοση: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
ανά: Shen-Jun Yuan, κ.ά.
Έκδοση: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
ανά: Ling Wang, κ.ά.
Έκδοση: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
ανά: Hitesh Kumar, κ.ά.
Έκδοση: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
ανά: Liu C, κ.ά.
Έκδοση: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
ανά: Vandana L Gaopande, κ.ά.
Έκδοση: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
ανά: Nicholas R. Hum, κ.ά.
Έκδοση: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
ανά: Andrew Sulaiman, κ.ά.
Έκδοση: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
ανά: Alaa M. Ghallab, κ.ά.
Έκδοση: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
ανά: Lei Di, κ.ά.
Έκδοση: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
ανά: Weiguang Liu, κ.ά.
Έκδοση: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
ανά: Jingyue Fu, κ.ά.
Έκδοση: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
ανά: Xi Liu, κ.ά.
Έκδοση: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
ανά: Jingchao Wang, κ.ά.
Έκδοση: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
ανά: Dayanidhi Raman, κ.ά.
Έκδοση: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
ανά: Ammar Said Suliman, κ.ά.
Έκδοση: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
ανά: Yen-Dun Tony Tzeng, κ.ά.
Έκδοση: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
ανά: Weiguang Liu, κ.ά.
Έκδοση: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
ανά: Hanan Ahmed Wahba, κ.ά.
Έκδοση: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
ανά: Mahdi Aghili, κ.ά.
Έκδοση: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
ανά: Sofia RE. Mason, κ.ά.
Έκδοση: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
ανά: Srijan Basu, κ.ά.
Έκδοση: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
ανά: Omran Saifi, κ.ά.
Έκδοση: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
ανά: Yueh-Te Lin, κ.ά.
Έκδοση: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
ανά: Elizabeth R. Berger, κ.ά.
Έκδοση: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
ανά: Magdalena Niedolistek, κ.ά.
Έκδοση: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
ανά: Lisa Agnello, κ.ά.
Έκδοση: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
ανά: Mohammed Amrallah A., κ.ά.
Έκδοση: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
ανά: Yi-Fen Chiang, κ.ά.
Έκδοση: (2023-01-01)